GLYCOSYLTRANSFERASE ACTIVATION IN COLONIC ADENOCARCINOMA
GLYCOSYLTRANSFERASE ACTIVATION IN COLONIC ADENOCARCINOMA
批准号:
2084001
负责人:
Eric Holmes
金额:
$6.75万
依托单位国家:
美国
项目类别:
财政年份:
1988
资助国家:
美国
项目状态:
已结题
起止时间:
1988-09-01 至 1993-08-31
关键词:
adenocarcinoma colon neoplasms enzyme activity enzyme induction /repression gene expression glycolipids glycosyltransferase human tissue immunochemistry laboratory mouse laboratory rabbit membrane lipids molecular oncology neoplastic cell neoplastic transformation tissue /cell culture tumor antigens
中文摘要
糖脂代谢的戏剧性变化与
致癌转化涉及膜的特定作用
糖脂在调节细胞生长和细胞识别中的作用。
这些变化导致肿瘤特异性膜抗原的产生。
它们在诊断上是有用的,并且可以作为潜在的目标
免疫疗法。尽管这些肿瘤的许多例子
抗原已经被记录在案,但可用的信息不多
与生物合成的调节机制有关的
阻止这些碳水化合物结构在正常人群中表达
细胞和组织,并被激活以联合产生它们
与肿瘤的发生有关。各种基于乳糖系列的碳水化合物
抗原已被描述为存在于人类腺癌中。
最近的证据表明,正常情况下一种
未表达的β1导致3N-乙酰氨基葡萄糖基转移酶
内酯系列链合成所需的物质存在于结肠中
上皮细胞,并导致这些抗原的积累。
此应用程序建议将这些观察扩展到在
该酶和其他相关酶活性的详细相互作用
随着各种末级结构的合成,
发生在这些肿瘤中。Beta 1通向3N-
联合激活的乙酰氨基葡萄糖基转移酶
对其致癌作用将进行广泛的研究。这项活动将是
以腺癌细胞株为特征,纯化到
来自可溶来源的同质性,如血清或牛奶,这
研究了酶的物理性质,抗体将
为它做好准备,这些抗体将用于研究
分离编码该酶的cDNA克隆。然后,这将是
导致了对这两个过程中基因表达调控的研究
发育和肿瘤发生。
这些研究将提供更多关于
与肿瘤发生相关的生化变化
这导致了一系列重要的和潜在有用的
人类肿瘤抗原,以乳糖为基础的碳水化合物抗原。
英文摘要
Dramatic changes in glycolipid metabolism associated with
oncogenic transformation implicate a specific role for membrane
glycolipids in regulation of cell growth and cellular recognition.
These changes give rise to tumor specific membrane antigens
which are useful diagnostically and as potential targets for
immunotherapy. Although many examples of these tumor
antigens have been documented, not much information is available
relating to the mechanism of regulation of biosynthesis which
prevents expression of these carbohydrate structures in normal
cells and tissues and is activated to produce them in association
with oncogenesis. A variety of lacto-series based carbohydrate
antigens have been described to occur in human adenocarcinomas.
Recent evidence has shown that activation of a normally
unexpressed beta 1 leads to 3N-acetyl-glucosaminyltransferase
required for lacto-series chain synthesis occurs in colonic
epithelial cells and results in accumulation of these antigens.
This application proposes to extend these observations to study in
detail interactions of this and other enzyme activities associated
with the synthesis of a variety of end-stage structures which
occur in these tumors. The beta 1 leads to 3N-
acetylglucosaminyltransferase which is activated in association
with oncogenesis will be extensively studied. This activity will be
characterized in adenocarcinoma cell lines, purified to
homogeneity from a soluble source such as serum or milk and this
enzyme studied in terms of its physical properties, antibodies will
be prepared against it and these antibodies will be used in studies
to isolate cDNA clones which encode the enzyme. This will then
lead to studies of the regulation of gene expression during both
development and oncogenesis.
These studies will provide further information relating to the
biochemical changes occurring in association with oncogenesis
which gives rise to an important and potentially useful series of
human tumor antigens, lacto-series based carbohydrate antigens.
期刊论文(21)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
GDP-fucose:GM1 alpha 1----2fucosyltransferase is activated in parenchymal cells of rat liver during early stages of N-2-acetylaminofluorene induced hepatocarcinogenesis.
GDP-岩藻糖:GM1 α 1----2岩藻糖基转移酶在 N-2-乙酰氨基芴诱导的肝癌发生的早期阶段在大鼠肝实质细胞中被激活。
DOI:
10.1093/carcin/11.1.89
发表时间:
1990
期刊:
Carcinogenesis
影响因子:
4.7
作者:
[Holmes,EH]
通讯作者:
Holmes,EH
Brefeldin A induced inhibition of de novo globo- and neolacto-series glycolipid core chain biosynthesis in human cells. Evidence for an effect on beta 1-->4galactosyltransferase activity.
Brefeldin A 诱导抑制人类细胞中的从头球形和新乳糖系列糖脂核心链生物合成。
DOI:
--
发表时间:
1992
期刊:
The Journal of biological chemistry
影响因子:
--
作者:
[Sherwood,AL, Holmes,EH]
通讯作者:
Holmes,EH
Characterization of two monoclonal antibodies specific for lacto-series type 1 chain Gal beta 1----3GlcNAc-terminal structures.
对乳系列 1 型链 Gal beta 1----3GlcNAc 末端结构具有特异性的两种单克隆抗体的表征。
DOI:
10.1016/0003-9861(90)90567-i
发表时间:
1990
期刊:
Archives of biochemistry and biophysics
影响因子:
3.9
作者:
[Holmes,EH, Greene,TG]
通讯作者:
Greene,TG
Biosynthesis of fucose containing lacto-series glycolipids in human colonic adenocarcinoma Colo 205 cells.
人结肠腺癌细胞 Colo 205 细胞中含岩藻糖的乳系列糖脂的生物合成。
DOI:
10.1016/0003-9861(89)90479-7
发表时间:
1989
期刊:
Archives of biochemistry and biophysics
影响因子:
3.9
作者:
[Holmes,EH, Levery,SB]
通讯作者:
Levery,SB
1H NMR studies of a biosynthetic lacto-ganglio hybrid glycosphingolipid: confirmation of structure, interpretation of "anomalous" chemical shifts, and evidence for interresidue amide-amide hydrogen bonding.
生物合成乳神经节杂合鞘糖脂的 1H NMR 研究:结构确认、“异常”化学位移的解释以及残基间酰胺-酰胺氢键的证据。
DOI:
10.1021/bi00119a016
发表时间:
1992
期刊:
Biochemistry
影响因子:
2.9
作者:
[Levery,SB, Holmes,EH, Harris,DD, Hakomori,S]
通讯作者:
Hakomori,S
共 20 条
ADMINISTRATIVE CORE
-
批准号:8360694
-
项目类别:
-
资助金额:$50.46万
-
财政年份:2011
-
负责人:Eric Holmes
-
依托单位:
Cellular Basis of Immunological and Neurological Disease
-
批准号:7471544
-
项目类别:
-
资助金额:$232.08万
-
财政年份:2001
-
负责人:Eric Holmes
-
依托单位:
INBRE II: Hawaii Statewide Research & Education Partnership (HSREP)
-
批准号:8137032
-
项目类别:
-
资助金额:$297.69万
-
财政年份:2001
-
负责人:Eric Holmes
-
依托单位:
INBRE II: Hawaii Statewide Research & Education Partnership (HSREP)
-
批准号:8288745
-
项目类别:
-
资助金额:$294.95万
-
财政年份:2001
-
负责人:Eric Holmes
-
依托单位:
INBRE II: Hawaii Statewide Research & Education Partnership (HSREP)
-
批准号:7900700
-
项目类别:
-
资助金额:$323.57万
-
财政年份:2001
-
负责人:Eric Holmes
-
依托单位:
ANTIBODY TARGETING TO PSMA IN PROSTATIC TUMORS
-
批准号:2776431
-
项目类别:
-
资助金额:$10.0万
-
财政年份:1999
-
负责人:Eric Holmes
-
依托单位:
HUMAN FUCOSYLTRANSFERASE STRUCTURE/FUNCTION ANALYSIS
-
批准号:6350191
-
项目类别:
-
资助金额:$34.97万
-
财政年份:1997
-
负责人:Eric Holmes
-
依托单位:
HUMAN FUCOSYLTRANSFERASE STRUCTURE/FUNCTION ANALYSIS
-
批准号:2871891
-
项目类别:
-
资助金额:$33.68万
-
财政年份:1997
-
负责人:Eric Holmes
-
依托单位:
HUMAN FUCOSYLTRANSFERASE STRUCTURE/FUNCTION ANALYSIS
-
批准号:2654220
-
项目类别:
-
资助金额:$33.06万
-
财政年份:1997
-
负责人:Eric Holmes
-
依托单位:
HUMAN FUCOSYLTRANSFERASE STRUCTURE/FUNCTION ANALYSIS
-
批准号:2009747
-
项目类别:
-
资助金额:$32.46万
-
财政年份:1997
-
负责人:Eric Holmes
-
依托单位:
HUMAN FUCOSYLTRANSFERASE STRUCTURE/FUNCTION ANALYSIS
-
批准号:6150220
-
项目类别:
-
资助金额:$34.31万
-
财政年份:1997
-
负责人:Eric Holmes
-
依托单位:
IMMUNOTOXIN THERAPY FOR PROSTATIC CARCINOMAS
-
批准号:2009407
-
项目类别:
-
资助金额:$10.0万
-
财政年份:1996
-
负责人:Eric Holmes
-
依托单位:
SPECIFIC INHIBITORS OF SERINE/THREONINE PHOSPHATASES
-
批准号:2115749
-
项目类别:
-
资助金额:$10.0万
-
财政年份:1996
-
负责人:Eric Holmes
-
依托单位:
MONOCLONAL ANTIBODIES TO DNA BASE LESIONS
-
批准号:2110761
-
项目类别:
-
资助金额:$9.92万
-
财政年份:1995
-
负责人:Eric Holmes
-
依托单位:
SMALL INSTRUMENTATION PROGRAM
-
批准号:3523527
-
项目类别:
-
资助金额:$0.66万
-
财政年份:1990
-
负责人:Eric Holmes
-
依托单位:
GLYCOSYLTRANSFERASE ACTIVATION IN COLONIC ADENOCARCINOMA
-
批准号:3071860
-
项目类别:
-
资助金额:$6.75万
-
财政年份:1988
-
负责人:Eric Holmes
-
依托单位:
GLYCOSYLTRANSFERASE ACTIVATION IN COLONIC ADENOCARCINOMA
-
批准号:3071858
-
项目类别:
-
资助金额:$5.18万
-
财政年份:1988
-
负责人:Eric Holmes
-
依托单位:
GLYCOSYLTRANSFERASE ACTIVATION IN COLONIC ADENOCARCINOMA
-
批准号:3071859
-
项目类别:
-
资助金额:$5.4万
-
财政年份:1988
-
负责人:Eric Holmes
-
依托单位:
SMALL INSTRUMENTATION PROGRAM
-
批准号:3523303
-
项目类别:
-
资助金额:$0.5万
-
财政年份:1988
-
负责人:Eric Holmes
-
依托单位:
GLYCOSYLTRANSFERASE ACTIVATION IN COLONIC ADENOCARCINOMA
-
批准号:3071861
-
项目类别:
-
资助金额:$6.75万
-
财政年份:1988
-
负责人:Eric Holmes
-
依托单位:
海外基金